Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
Ruiz A, Blanch-Lombarte O, Jimenez-Moyano E, Ouchi D, Mothe B, Peña R, Galvez C, Genescà M, Martinez-Picado J, Goulder P, Barnard R, Howell B, Clotet B, Prado JG. Ruiz A, et al. Among authors: clotet b. Front Immunol. 2019 Jan 22;9:3162. doi: 10.3389/fimmu.2018.03162. eCollection 2018. Front Immunol. 2019. PMID: 30723480 Free PMC article.
RNA interference of HIV replication.
Martínez MA, Clotet B, Esté JA. Martínez MA, et al. Among authors: clotet b. Trends Immunol. 2002 Dec;23(12):559-61. doi: 10.1016/s1471-4906(02)02328-1. Trends Immunol. 2002. PMID: 12464559
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, Domingo P, Vilaró J, Llibre JM, Viciana P, Hertogs K, Boucher C, D'Aquila RT, Clotet B; SWATCH Study Team. Martinez-Picado J, et al. Among authors: clotet b. Ann Intern Med. 2003 Jul 15;139(2):81-9. doi: 10.7326/0003-4819-139-2-200307150-00007. Ann Intern Med. 2003. PMID: 12859157 Clinical Trial.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Weber J, Rangel HR, Chakraborty B, Tadele M, Martinez MA, Martinez-Picado J, Marotta ML, Mirza M, Ruiz L, Clotet B, Wrin T, Petropoulos CJ, Quiñones-Mateu ME. Weber J, et al. Among authors: clotet b. J Gen Virol. 2003 Aug;84(Pt 8):2217-2228. doi: 10.1099/vir.0.19123-0. J Gen Virol. 2003. PMID: 12867654
1,144 results